These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11943110)

  • 1. [Drugs and cost-effectiveness].
    Marín Moreno S
    Med Clin (Barc); 2002 Mar; 118(11):438; author reply 438-9. PubMed ID: 11943110
    [No Abstract]   [Full Text] [Related]  

  • 2. [The need for joint evaluation of pharmaceutical expenditure and the health outcomes obtained].
    Soto Álvarez J
    Gac Sanit; 2011; 25(3):257. PubMed ID: 21459490
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug utilization decisions should be based on cost-benefit data].
    Bengt J; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Apr 18-24; 102(16):1264-5; discussion 1265. PubMed ID: 15921102
    [No Abstract]   [Full Text] [Related]  

  • 4. When is it cost-effective to change the behavior of health professionals?
    Mason J; Freemantle N; Nazareth I; Eccles M; Haines A; Drummond M
    JAMA; 2001 Dec; 286(23):2988-92. PubMed ID: 11743840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effective drug utilization--what can the national drug agency do?].
    Wesenberg GR; Madsen S
    Tidsskr Nor Laegeforen; 2001 Aug; 121(18):2207. PubMed ID: 11572010
    [No Abstract]   [Full Text] [Related]  

  • 6. The costs of making practice more cost-effective.
    Weeks WB; Wallace AE
    JAMA; 2002 Apr; 287(13):1648; author reply 1649-50. PubMed ID: 11926883
    [No Abstract]   [Full Text] [Related]  

  • 7. The economic aspects of drug use.
    Haaijer-Ruskamp FM; Dukes MN
    WHO Reg Publ Eur Ser; 1993; 45():125-45. PubMed ID: 8442842
    [No Abstract]   [Full Text] [Related]  

  • 8. [Measures to contain drug costs and quality indicators in the use of drugs: prescribe less or prescribe better?].
    Arnau JM
    Aten Primaria; 1994 Mar; 13(4):155-8. PubMed ID: 8180298
    [No Abstract]   [Full Text] [Related]  

  • 9. Insurance issues and new treatments.
    Neels K
    J Am Dent Assoc; 1994 Jan; 125 Suppl():45S-53S. PubMed ID: 8294675
    [No Abstract]   [Full Text] [Related]  

  • 10. Serving patient needs while implementing cost effectiveness programs in health care administration.
    Tootelian DH
    Health Mark Q; 1994; 11(3-4):161-73. PubMed ID: 10137013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of copayments and generic substitution on the use and costs of prescription drugs.
    Smith DG
    Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consumption of drugs: policies and social pact].
    Antoñanzas Villar F
    Gac Sanit; 2000; 14(2):93-6. PubMed ID: 11203054
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of limited lists and formularies: are they cost-effective?
    Pearce MJ; Begg EJ
    Pharmacoeconomics; 1992 Mar; 1(3):191-202. PubMed ID: 10147029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Five experts interviewed about drugs. Benefits for the patients could have been more emphasized].
    Melander A
    Lakartidningen; 2002 Feb; 99(9):872-3. PubMed ID: 11962005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Containing pharmacy costs in an emergency department].
    Ucha Samartín M; Martínez López de Castro N; Pichel Loureiro A; Amador Barciela L
    Rev Calid Asist; 2012; 27(5):298-9. PubMed ID: 22704689
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibiotics in Valencian Community: controlling expenditure but not consumption].
    Colomina-Rodríguez J; Gil-Tomás JJ; Pérez-Doñate V; Borrás-Máñez M
    Rev Esp Quimioter; 2014 Sep; 27(3):227-9. PubMed ID: 25229382
    [No Abstract]   [Full Text] [Related]  

  • 17. Physicians, Accountable Care, And Drugs.
    Weil AR
    Health Aff (Millwood); 2016 Mar; 35(3):387. PubMed ID: 26953288
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cost-effective drug utilization--thiazides are still available].
    Lund-Roland L
    Tidsskr Nor Laegeforen; 2001 Sep; 121(22):2637. PubMed ID: 11668768
    [No Abstract]   [Full Text] [Related]  

  • 19. Does antidepressant step therapy fuel the law of unintended consequences?
    Greden JF
    Am J Psychiatry; 2010 Oct; 167(10):1148-51. PubMed ID: 20889657
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effective prescribing.
    Sherman DS
    Contemp Longterm Care; 1993 Jan; 16(1):64, 66. PubMed ID: 10123530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.